Home » News & Politics » The Technology Behind Bluebird Bio

The Technology Behind Bluebird Bio

Written By Bloomberg Tech on Friday, May 19, 2017 | 01:18 PM

 
May.19 -- Bluebird Bio CEO Nick Leschly discusses gene therapy, Boston's biotech scene, and venture capital with Bloomberg's Caroline Hyde on "Bloomberg Technology" at the Museum of Science in Boston on May 9.